Skip to main content

Articles

pharma courses

  • THERAPEUTIC POTENTIAL OF VENOMOUS PEPTIDE IN VARIOUS DISEASES

    ABOUT AUTHORS:
    1*Anjali Choba, 2Shikha Attri
    1M.Pharma in pharmacology from shoolini university solan, himachal pradesh
    2M.Pharm in pharmaceutical chemistry from lachoo memorial college of science and technology, jodhpur
    *anji5057@yahoo.in

  • REVIEW ON ANIMAL MODELS OF Dementia AND ALZHEIMER’S DISEASE

    About Author:
    Richa Shrivastava
    National Institute Of Pharmaceutical Education And Research
    Niper, Guwahati
    richashrivastava18888@gmail.com

    Dementia is defined as a loss of intellectual abilities that is severe enough to interfere with social or occupational functioning.
    Alzheimer’s disease (AD)
    is most common cause of dementia. 50-70% of all cases of dementia are due to Alzheimer’s disease.
    AD is characterized by early memory deficits, followed by gradual erosion of other cognitive functions. The most severe neuropathological changes occur in the hippocampus, followed by association cortices or subcortical structures, including the amygdale and nucleus basalis of Meyhert.

  • DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR METRONIDAZOLE AND NORFLOXACIN IN TABLETS DOSAGE FORM

    ABOUT AUTHORS:
    Yogesh Kumar Jain*, Dr. R.P.S. Rathore, Udaibhan Singh Rathore, Dharmendra Singh sisodiya,  Vijendra Singh Chauhan
    Bhupal Nobles’ College of Pharmacy,
    Udaipur – 313002, Rajasthan, India.
    *jain.yogesh1987@gmail.com

  • AYURVASTRA: A NOVEL USE OF HERBAL DRUGS

    About Authors:
    Neha Karekar, Prit Lakhani, Ujas Patel
    Mumbai Educational Trust
    Institute of Pharmacy
    Associate Pharmacy Education Officer 2012-2013
    Indian Pharmaceutical Association Students' Forum Maharashtra State Branch
    2009nehak@gmail.com

  • THALIDOMIDE AND ITS ANALOGUES IN ANTICANCER THERAPY

    ABOUT AUTHORS:
    Shikha Attri, Arti Choudhary, Devendra Gupta
    M.Pharm in Pharmaceutical Chemistry, Lachoo
    Memorial College of Science and Technology,
    Jodhpur University, Rajasthan University Of Health Sciences, Jaipur
    *shikhu921@gmail.com

  • A REVIEW ON: WATER ANALYSIS IN PHARMA INDUSTRIES

    ABOUT AUTHORS:
    Narasimha Gandhi1, Ravisankar M*1, Harini K2, Ananda Thangadurai S2
    1Kemwell bio pharma pvt ltd, Neelamangala, Bangalore.
    2Swami Vivekanandha College of Pharmacy, Department of Pharmaceutical analysis,
    Elayampalayam, Thiruchengode, Namakkal Dt.
    *pharmaravi18@gmail.com

  • SUPERDISINTEGRANTS: A REVIEW

    About Authors:
    Hemant Rathod*, M.P.Khinchi, Dilip Agrawal, Natasha Sharma

    *Department of Pharmaceutics
    Kota College of Pharmacy,
    Kota, Rajasthan, India
    *hemant2787@gmail.com

    Abstract
    Fast dissolving, fast melting, chewable and orally dissolving or disintegrating tablets are solid dosage forms that disintegrate rapidly and dissolve in the mouth without water. These products have staying power in the marketplace because they appeal to consumers and support increased compliance among users as well as provide effective life-cycle management. The principle challenge with orally disintegrating tablets (ODTs) is to develop tablet formulations that deliver rapid disintegration, pleasant mouth feel and high breaking force for tablet robustness. Superdisintegrants affect a range of formulation parameters; including the rate of disintegration, tablet breaking force, and mouth feel i.e. Polyplasdone XL-10 superdisintegrant provides optimal performance in ODT formulations.

  • AN OVERVIEW: MELT-IN-MOUTH TABLETS

    About Authors:
    Hemant Rathod*, Shakti Shekhawat, Jimit Shah, Parth Gandhi
    Department of Pharmaceutics,
    Kota College of Pharmacy, Kota, Rajasthan.
    *hemant2787@gmail.com

  • GLOBAL SCENARIO OF HERBAL DRUG TODAY AND TOMORROW

    About Authors:
    1Bhatt Mehul K.*, 2Dr. Captain A.D.
    1Department of Pharmacognosy,
    Shivam Pharmaceutical Studies & Research Centre,
    Valasan-388 326, Anand, Gujarat, India.
    2Department of Pharmaceutical chemistry
    A. R. College and G. H Patel institute of Pharmacy,
    Vallabh Vidyanagar, Anand-380 015, Gujarat, India.
    *mkb_0999@yahoo.co.in

    Absract:
    Today estimate that about 80% of people in developing countries still relays on traditional medicine based largely on species of plants and animals for their primary health care. India has one of the richest plant traditions in the world. These are estimated to by around 25,000 effect plant based formulations, used in folk medicine and known to rural communities in India. Indias share in the export of herbals is USD 63 billion which is just 0.2% of the global herbal market. So there is obviously vast scope for Indian manufacturers for entering the growing worldwide opportunity of business in herbal pharmaceutical field. We also have to focus on standardization of herbal products. Pharmaceutical export promotion council i.e PHARMEXCIL is ready to play a key role in this regards. Currently, a majority of the adverse events related to the use of herbal products and herbal medicines that are reported are attributable either to poor product quality or to improper use. Inadequate regulatory measures, weak quality control systems and largely uncontrolled distribution channels may have been contribution to the occurrence of such events. So Pharmacovigilance of herbal medicines is required.

  • SOP PREPARATION AND FORMAT DESIGNING

    ABOUT AUTHOR:
    MR. Gunjegaonkar S.M.
    Assistance Professor.
    Dept. of Pharmacology JSPM’s Charak College of Pharmacy and Research, Wagholi, Pune, Maharashtra.
    gunjeshiv@gmail.com

    INTRODUCTION:
    Standard operating procedures are integral part of all the pharmaceutical companies. To obtain the standard quality product intended for human and animal use, manufactured product must have gone through CGMP rules and regulations. Standard operating procedure is an also part of CGMP and GDP (Good documentation practices). Any process, procedure, activity being carried out at any time, at any step that has to perform according to SOP. Standard operating procedure must be written by a subject expert considering the GMP, working feasibility, accountability and authorized by authorized persons. In the face of a challenging regulatory environment, some leading Pharmaceutical companies have found ways to improve quality and costs significantly. To drive this kind of beneficial change, companies must first create a culture where quality objectives are transparent, well understood, and undoubtedly these goals can be achieved by following certain sets of procedures called as “Standard Operating Procedures” (SOP). Procedures are essential for any plant’s effectiveness and efficiency, and they are regulatory requirement in the Pharmaceutical Industry. A typical Pharmaceutical Industry has an average of 1200- 1300 SOPs. A Parenteral Drug Association (PDA) survey found that a typical pharmaceutical company must manage an average of 1250 CGMP-required SOPs and that the average maintenance burden is 15,000 h per firm.

    [adsense:336x280:8701650588]

Subscribe to Articles